A phase III trial of SB-204 in patients with acne vulgaris
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- 13 Nov 2017 New trial record
- 07 Nov 2017 According to a Novan Inc. media release, this pivotal trial is required before the filing of a New Drug Application for SB-204 in the treatment of acne vulgaris.
- 07 Nov 2017 According to a Novan Inc. media release, the company anticipated to finalize the clinical trial execution after joint discussion of the trial protocol with the US FDA in the first quarter of 2018.